News
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
NACOGDOCHES COUNTY, Texas (KTRE) - A water company in Nacogdoches County has rescinded a boil notice. Lilly Grove SUD ...
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the ...
The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...
Highlights for May 8-14 include Lambrini Girls, Katy Perry, Gang of Four, Lucius, Allison Russell and Sharon Van Etten.
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.
The new research and development site will combine research, process development and clinical trial manufacturing ...
Shares have slumped 60% since the Wall Street Journal reported in April that the company was preparing to file for bankruptcy ...
Walmart may have overextended itself...or not, depending on who you ask. As noted by GoNintendo, there are reports of Walmart ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes ...
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its annual sales forecast on Wednesday, citing a decline in its US market share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results